Minerva Surgical raises $9m for endometrial ablation tech

Minerva Surgical has raised $9.2 million from 17 investors as part of a $10 million offering, according to a document filed with the SEC this week.
The Redwood City, CA.-based company makes the Minerva endometrial ablation system – a treatment designed to help women manage heavy menstrual bleeding.
Heaving bleeding, which occurs in women between the ages of 30 and 40, is a common diagnosis; the condition affects 1 in 3 women, according to Minerva Surgical.
The company’s technology works by delivering plasma energy to the tissue lining of a woman’s uterus. The doctor dilates the patient’s cervix and inserts a silicone array into the patient’s uterus. There, the silicone array opens and a cervical balloon is inflated to protect the cervix.
The doctor then uses the Minerva System to conduct a series of tests. After the tests are finished, the doctor delivers two minutes of customized plasma energy to treat the patient’s uterine lining, according to Minerva Surgical.
Finally, the cervical balloon is deflated and the silicone array is closed and removed from the patient’s uterus.
Minerva surgical touts that the entire treatment usually takes less than four minutes.
The post Minerva Surgical raises $9m for endometrial ablation tech appeared first on MassDevice.

Source: Mass Device - January 4, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured Funding Roundup Women's Health Minerva Surgical Inc. Source Type: news